Related Experiment Videos
Molecular therapeutics: promise and challenges
Elise C Kohn1, Yiling Lu, Hongwei Wang
1Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
Seminars in Oncology
|March 31, 2004
Summary
Analyzing tumor genetic and epigenetic changes enables personalized cancer medicine. This approach promises more effective, less toxic therapies tailored to individual patients.
Area of Science:
- Oncology
- Genomics
- Proteomics
- Molecular Medicine
Background:
- Global analysis of genetic and epigenetic aberrations in tumors is advancing.
- Functional genomics and proteomics offer insights into cancer pathophysiology.
Purpose of the Study:
- To translate advances in cancer genomics and proteomics into clinical applications.
- To highlight the need for novel clinical trial designs for targeted therapeutics.
- To emphasize the potential of individualized molecular medicine in cancer treatment.
Main Methods:
- Global analysis of genetic and epigenetic aberrations.
- Functional genomics and proteomics.
- Chemical genomics.
- Development of targeted therapeutics.
- Novel clinical trial designs.
Main Results:
- Emerging technologies provide a comprehensive understanding of cancer pathophysiology.
- Linking genomics, proteomics, and chemical genomics expands targeted therapeutic options.
- New drugs are becoming available for clinical evaluation.
Conclusions:
- Individualized molecular medicine, based on patient-specific tumor genetics, will revolutionize cancer therapy.
- This approach promises more effective treatments with reduced toxicity.
- The integration of advanced technologies is crucial for realizing the potential of precision oncology.